Indication:
RABIVAX-S is indicated for the prevention of rabies in children and adults. It can be used for pre-exposure and post-exposure prophylaxis.

Route of Administration:

• Intramuscular (IM)
• Intradermal (ID)

Immunization Schedule:

Pre-exposure Prophylaxis (High-risk populations):

• Intramuscular: 1 ml on Days 0, 7, and 21/28.
• Intradermal: 0.1 ml on Days 0, 7, and 21/28.

Post-exposure Prophylaxis (Unimmunized individuals):

• Intramuscular: 1 ml on Days 0, 3, 7, 14, and 28.
• Intradermal: 0.1 ml on Days 0, 3, 7, and 28.

Post-exposure (Previously Immunized):

• Single Dose on Days 0 and 3 (IM: 1 ml or ID: 0.1 ml).

Indication: For active immunization to prevent invasive disease, pneumonia, and otitis media caused by 13 strains of Streptococcus pneumoniae. Recommended for infants, young children, and individuals at increased risk due to health conditions, as well as adults aged 50 years and older.
Route: Administered as an intramuscular injection, typically in the anterolateral aspect of the thigh for infants and the deltoid muscle of the upper arm for older children and adults.
Immunization Schedule: For infants, a primary series of 3 doses at 6 weeks, 10 weeks, and 14 weeks of age, followed by a booster dose at 12-15 months. For unvaccinated older children and adults, the schedule varies based on age and risk factors, typically as a single dose or a catch-up schedule.